Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive examination. Supporters often emphasize the opportunity for meaningful therapeutic gains, particularly in conditions where conventional medications have proven ineffective. However, this is to consider the significant financial burden associated with CPI stem cell